Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: COCH) is a medical device company specializing in implantable hearing technology, including its Esteem totally implantable hearing system and Acclaim cochlear implant platform. The company reached the public markets through a de-SPAC merger with Anzu Special Acquisition Corp I, a blank-check vehicle sponsored by Anzu Partners that completed its IPO in 2021. The business combination closed in 2022, after which Envoy Medical began trading under the COCH ticker on Nasdaq. The August 2022 10-Q filing reflects the company's early post-merger operating period within the medical device and hearing health sector. For complete filing history, SPAC deal analytics, and sponsor intelligence on COCH, sign up for full data access at SpacDesk.